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Abstract: McArdle disease (glycogenosis-V) is associated with exercise intolerance, however,
how it affects an important marker of cardiometabolic health as it is adiposity remains unknown.
We evaluated the association between physical activity (PA) and adiposity in patients with McArdle
disease. We assessed 199 adults of both sexes (51 McArdle patients (36 ± 11 years) and 148 healthy
controls (35 ± 10 years)). Body fat (BF) was determined using dual-energy X-ray absorptiometry
(DXA) method and each patient’s PA was assessed with the International PA Questionnaire (IPAQ).
Although body mass index values did not differ between patients and controls, McArdle patients had
significantly higher values of BF in all body regions (p < 0.05) and higher risk of suffering obesity
(odds ratio (OR): 2.54, 95% confidence interval (95% CI): 1.32–4.88). Male patients had higher BF and
obesity risk (OR: 3.69, 95% CI: 1.46−9.34) than their sex-matched controls, but no differences were
found within the female sex (p < 0.05). In turn, active female patients had lower trunk BF than their
inactive peers (p < 0.05). Males with McArdle seem to have adiposity problems and a higher risk of
developing obesity than people without the condition, while female patients show similar or even
better levels in the trunk region with an active lifestyle. Therefore, special attention should be given
to decrease adiposity and reduce obesity risk in males with McArdle disease.
Keywords: DXA; fat mass; exercise; physical activity; inactivity; obesity
1. Introduction
McArdle disease, also known as glycogenosis type V, is a myopathy caused by inherited deficiency
of the muscle isoform of glycogen phosphorylase, myophosphorylase [1,2]. The activity of this enzyme is
typically absent with a subsequent blockade of muscle glycogen breakdown [3]. Affected individuals
present with exercise intolerance in the form of acute crises of fatigue and muscle stiffness and
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contractures, especially at the start of exercise, which is usually attenuated if exercise is stopped or
intensity is reduced [4]. These episodes can be accompanied by rhabdomyolysis, as reflected by abrupt
elevations in serum creatine kinase (CK) levels (a marker of muscle damage) and myoglobinuria (‘dark
urine’) [5]. As a result, physical activity (PA) has traditionally been contraindicated in these patients
by clinicians [6–10] to the extent that some authors have suggested that clinicians should encourage
patients to adopt an active rather than a sedentary lifestyle [6,7,11]. This inactivity, in addition to not
improving the clinical condition or attenuating the progression of muscle damage [10,12], exacerbates
the exercise intolerance of these patients [11–13] and results in a deterioration of physical capacity
with a consequent impairment of quality of life [10–12,14]. In turn, exercise and PA seems to be
the main modifier of the clinical course of McArdle disease [7,9]. In this context, previous research
has shown that regular, light/moderate-intensity aerobic exercise interventions (e.g., brisk walking),
improve the physical capacity (expressed as cardiorespiratory fitness (CRF)) of patients with McArdle
disease [15–18], and benefits have also been reported in this patient population with a supervised
resistance exercise intervention [19].
In relation to the body composition, inactivity and low CRF are associated with a higher prevalence
of obesity [20,21] and with a higher risk of all-cause mortality [22–25]. In contrast, higher levels of
PA and/or CRF reduce the risk of premature death [24,26] and improve body composition, as well as
decreasing and increasing body fat (BF) and lean mass, respectively [27]. In McArdle patients, higher
PA levels are associated with a healthier body composition phenotype (i.e., higher lean and bone mass),
with active patients showing higher lean mass than their sedentary patient peers [28]. Thus, inactivity
might likely lower the daily energy expenditure of these patients, potentially leading to an increase
in adiposity and thus to a decrease in patients’ health status. However, whether the levels of PA can
actually influence the adiposity accumulation and distribution has not been previously studied in
patients with McArdle disease.
The purpose of our study was to compare the BF profile of McArdle patients versus age/sex-matched
controls and to determine the effect of PA on the patients’ adiposity indices. In addition, we sought
to determine the risk factor for obesity in McArdle patients and especially, in inactive patients.
Our hypothesis was that BF would be higher in both male and female patients with McArdle disease
than in healthy individuals, and that an active lifestyle could improve this situation and reduce the
risk of obesity.
2. Materials and Methods
2.1. Patients
The study protocol was approved by the ethics committee of the Research Institute of the Hospital
12 de Octubre (Madrid, Spain; reference #16/081) and adhered to the tenets of the Declaration of
Helsinki 1961 (revision Edinburgh 2000). Patients were recruited for this study if they met the following
criteria: (i) genetic diagnosis of McArdle disease, that is, identification of the two mutant alleles in the
gene (PYGM) encoding myophosphorylase, as determined elsewhere [13] or, in those in whom only one
mutant allele has been identified to date, biopsy diagnosis or alternatively laboratory confirmation of
the ‘pathognomonic’ second wind phenomenon [12]; (ii) age 16 to 55 years; and (iii) having no condition
contraindicating dual-energy X-ray absorptiometry (DXA; e.g., pregnancy). A total of 51 patients with
McArdle disease (26 males, 25 females) who met all inclusion criteria and provided informed consent
were evaluated during June 2015–May 2019 (Figure 1). All the patients were informed of the aims and
procedures of the study, as well as of the possible risks and benefits.
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Figure 1. Flow diagram of patients with McArdle disease. * Death due to causes independent of
McArdle disease (i.e., cardiovascular disease).
2.2. Controls
Age- and gender-matched healthy subjects with previous DXA data collected by us using the
same equipment (see below) during the 2012–2019 period were used at as patient-controls with a ratio
as close as possible to ~1:3. Of the 849 possible subjects between 16 and 55 years, 168 subjects with
previous comorbidities were excluded from the sample (i.e., diabetes, cancer, etc.). Finally, we had 365
healthy male and 316 healthy females before matched. A total of 148 healthy subjects were contacted
again by us and agreed to serve as controls for the current study. Subjects written informed consent
was obtained from all of them. The following outcomes (see below) were recorded.
2.3. Anthropometry
Anthropometric measurements were obtained from all the participants immediately before DXA
assessment. Height was measured in the upright position, in underwear and barefoot on a stadiometer
with a precision of 1 mm (Seca 711; Hamburg, Germany). Body mass (BM) was determined with the
same requirements using a balance with a 100 g precision (Seca 711). Body mass index (BMI) was
calculated as body mass divided by height squared (kg/m2).
2.4. Adiposity
Total and regional BF were assessed in all the study participants using the same DXA equipment
(Hologic QDR Discovery; Bedford, MA, United States). DXA equipment was calibrated using a
lumbar spine phantom and following the Hologic guidelines. All DXA scan tests were analyzed
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using Physician’s Viewer, APEX System Software Version 3.1.2. (Hologic QDR Discovery; Bedford,
MA, United States). BF (kg) was calculated from total and regional analysis of the whole-body scan.
With this analysis, regional BF can be assessed with a coefficient of variation below 5% [29]. Scans were
made with subjects in a supine position, wearing light clothing with no metal and no shoes or jewelry.
To classify our sample into the obesity subgroup, we used the reference values established by Lohman
et al., with cut-off points at 25% BF in male and 35% BF in female [30].
2.5. Physical Activity in Patients
The Spanish long-form version of the International Physical Activity Questionnaire (IPAQ) was
used to assess the PA habits of the patients. This questionnaire records information on the frequency,
intensity, and duration of occupational, transport, home, and leisure/sport activities performed in
the previous seven days. It has been validated against accelerometry and is widely used to evaluate
the patterns of PA at the international level [31,32]; moreover, it has shown to have satisfactory
psychometric properties [31,33]. The IPAQ is also suitable for assessing PA in patient populations [31]
as it is divided in different parts, each addressing the specific types of PA that patients with chronic
disease are most likely to do [34]. This questionnaire has been used previously to assess the PA levels
of Spanish patients with McArdle disease [14,28].
We categorized participants into two groups according to their leisure-time PA levels: (i) “active”,
if they completed ≥600 metabolic equivalents (MET)·min·week−1, where 1 MET is the resting energy
expenditure, equivalent to an oxygen consumption of ~3.5 mL·kg−1·min−1 and 600 MET·min·week−1
corresponds to the minimum level of moderate–vigorous PA (150 min/week) recommended by
the World Health Organization for all adults [35]; or (ii) “inactive” if their PA levels were below
600 MET·min·week−1 [14,36]. The methods used to score the long IPAQ can be found at the IPAQ Web
site (www.ipaq.ki.se).
2.6. Statistical Analysis
Statistical analyses were performed with the IBM SPSS statistics package version 25 (SPSS, Inc.;
Chicago, IL, USA). The Kolmogorov–Smirnov test and graphical methods (normal probability plots)
were used to determine the normal distribution of the variables. Descriptive statistics were run on age
and anthropometric variables. Bivariate analysis was conducted using the chi-square test between
patients and controls, and active and inactive patients, both for the whole group and also separately by
sex. Odds ratios (OR) and their respective 95% confidence intervals (95% CI) were also calculated.
An analysis of covariance (ANCOVA) was used to determine if there existed differences in adiposity
indices (i.e., total/regional fat mass) for the comparison of (i) patients versus controls (as a whole and
also separately by sex), and of (ii) active versus inactive patients (within each sex). In all ANCOVA
analyses age, body mass, height, age of symptom onset, and frequency of rhabdomyolysis episodes
were used as covariates, and we applied the Bonferroni post-hoc test. Also, the continuous association
between time spent in moderate, vigorous, and leisure activities with the outcomes related to BF in the
study were explored via linear regression in males and females separately. The same set of covariates
used for the ANCOVA analysis was used. The statistical effect size (ES) was reported with the Hedge’s
g test for comparisons of unequal sample size. The level of statistical significance was set at p ≤ 0.05.
3. Results
A total of 51 patients (26 males, 25 females; aged 16 to 55 years) and 148 controls (76 males,
72 females) participated in the study (Table 1).
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Table 1. PYGM mutations identified in the study patients (n = 51).
Type of Mutation n %
p.R50X (c.148C>T)/p.R50X (c.148C>T) 22 43.14
p.R50X (c.148C>T)/p.G205S (c.613G>A) 6 11.76
p.R50X (c.148C>T)/p.W798R (c.2392T>C) 5 9.80
p.R50X (c.148C>T)/p.L5VfsX22 (c.13_14delCT) 2 3.92
p.R50X (c.148C>T)/p.Q755X (c.2263C>T) 2 3.92
p.G205S (c.613G>A)/c.1768 + 1G>A 2 3.92
p.G205S (c.613G>A)/p.G205S (c.613G>A) 1 1.96
p.R50X (c.148C>T)/c.1768 + 1G>A 1 1.96
p.R50X (c.148C>T)/p.R194W (c.580C>T) 1 1.96
p.R50X (c.148C>T)/p.V456M (c.1366G>A) 1 1.96
p.R194W (c.580C>T) + p.E797VfsX18 (c.2385_2386delAA)/p.R194W (c.580C>T) +
p.E797VfsX18 (c.2385_2386delAA) 1 1.96
p.W388SfsX34 (c.1162_1169delTGGCCGGT)/p.W388SfsX34 (c.1162_1169delTGGCCGGT) 1 1.96
p.K754NfsX49 (c.2262delA)/p.K754NfsX49 (c.2262delA) 1 1.96
p.R771PfsX33 (c.2310_2311dupCC)/p.R771PfsX33 (c.2310_2311dupCC) 1 1.96
p.W798R (c.2392T>C)/c.212_218dup (p.Q73HfsX7) 1 1.96
p.L5VfsX22 (c.13_14delCT)/p.K754Nfsx49 (c.2262delA) 1.96
p.Q734HfsX7 (c.211_217dupCGCAGCA)/p.Q734HfsX7 (c.211_218dupCGCAGCA) 1 1.96
c.244−3_244−2delCA/c.1093−1G>T 1 1.96
Table 2 shows main demographic data for the participants by group and sex. Patients and controls
as a whole group and divided by sex did not differ significantly in age, BM, or BMI adiposity, with the
exception of height, which was significantly higher in male controls than male patients (p < 0.05).
The results of total and regional BF values by group and sex are shown in Table 3.
Table 2. Anthropometric and descriptive data by group and sex.
Patients
(n = 51)
Controls
(n = 148)
Male Patients
(n = 26)
Male
Controls
(n = 76)
Female
Patients
(n = 25)
Female
Controls
(n = 72)
Sex (%)
Male 51 51
Female 49 49
Age (years) 36 ± 11 35 ± 10 33.6 ± 11.8 33.4 ± 11.4 38.0 ± 8.8 37.3 ± 8.5
BM (kg) 72.0 ± 15.4 70.5 ± 13.6 76.1 ± 14.7 77.5 ± 9.5 67.7 ± 15.3 63.1 ± 13.4
Height (cm) 170.5 ± 7.1 169.9 ± 13.4 174.2 ± 5.2 * 177.4 ± 5.7 166.6 ± 6.8 161.9 ± 14.5
BMI (kg/m2) 24.7 ± 5.0 27.2 ± 40.3 25.0 ± 4.2 24.7 ± 3.1 24.5 ± 5.8 30.0 ± 57.7
Data are mean ± standard deviation. Abbreviations: BM, body mass; BMI. body mass index. * p < 0.05 for male
patients vs. male controls.
Table 3. Adiposity (fat mass) indices by group and sex.
Fat Mass (kg)
Patients
(n = 51)
Controls
(n = 148)
Male Patients
(n = 26)
Male
Controls
(n = 76)
Female
Patients
(n = 25)
Female
Controls
(n = 72)
Whole-body 21.4 ± 0.8 17.5 ± 0.5 * 19.9 ± 0.8 15.6 ± 0.5 † 21.2 ± 0.8 20.2 ± 20.2
Subtotal body 20.6 ± 0.8 16.7 ± 0.5 * 19.0 ± 0.8 14.6 ± 0.5 † 20.4 ± 0.8 19.4 ± 19.4
Trunk 10.3 ± 0.4 8.1 ± 0.2 * 10.3 ± 0.4 7.8 ± 0.3 † 9.4 ± 0.5 8.8 ± 8.8
Arms (mean) 1.1 ± 0.1 0.9 ± 0.0 * 1.0 ± 0.0 0.8 ± 0.0 † 1.1 ± 0.1 1.1 ± 1.1
Legs (mean) 4.0 ± 0.2 3.3 ± 0.1 * 3.3 ± 0.2 2.6 ± 0.1 † 4.4 ± 0.2 4.2 ± 4.2
% BF 29.6 ± 1.0 25.3 ± 0.6 * 25.0 ± 0.8 19.7 ± 0.6 † 32.9 ± 0.9 31.7 ± 0.5
Data are mean ± standard error of the mean; a. * p < 0.05 for patients vs. controls; b. † p < 0.05 for male patients vs.
male controls.
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McArdle patients as a whole group (male and female together) showed significantly higher values
of whole-body and regional BF than their controls (between-group differences ranging from 17.5% to
21.4%, all p < 0.05). The ES values for these differences were large for the trunk (Hedge’s g = 0.86)
and medium for the rest of indices (Hedge’s g averaging 0.60). Likewise, when male patients were
compared with their sex-matched controls, all adiposity indices showed a similar trend, that is, greater
values (by 22% on average) in the former (Hedge’s g ranging from 0.01 to 1.02, all p < 0.05). In contrast,
no differences were found between female subgroups. The results of total and regional BF values in
patients based on PA levels are shown in Table 4. Nevertheless, no significant associations were found
when the continuous associations between time spent in moderate, vigorous, and leisure activities
with BF were studied.
Table 4. Fat mass indices in McArdle patients by physical activity levels and sex.
Fat Mass (kg)
Active Male
Patients
(n = 18)
Inactive Male
Patients
(n = 7)
Active Female
Patients
(n = 16)
Inactive Female
Patients
(n = 9)
Whole-body 19.8 ± 0.6 20.5 ± 1.1 23.3 ± 0.5 24.0 ± 0.7
Subtotal body 18.9 ± 0.6 19.6 ± 1.1 22.5 ± 0.5 23.2 ± 0.7
Trunk 10.3 ± 0.3 10.9 ± 0.6 10.3 ± 0.3 11.3 ± 0.4 *
Arms (mean) 1.0 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 1.3 ± 0.1
Legs (mean) 3.3 ± 0.2 3.3 ± 0.3 4.9 ± 0.2 4.7 ± 0.3
Data are mean ± standard error of the mean; * p = 0.05 for active female patients vs. inactive female patients.
The comparison between active and inactive McArdle patients distinguishing by sex revealed
significant differences only in trunk BF, with higher values in the female subgroup (by 9.7%, with a large
ES (Hedge’s g = 0.92; p < 0.05)). Similarly, the associations with obesity are shown in Table 5. McArdle
patients were significantly more likely to develop obesity than the control group (OR: 2.54, 95% CI:
1.32–4.88). Differentiating by sex, the male patients also showed a higher risk increase for obesity than
their counterparts (OR: 3.69, 95% CI: 1.46−9.34), but not the female group. Not significantly increased
risk was found in inactive patients.
Table 5. Association between McArdle disease and obesity (a), and physical activity and obesity only
in McArdle patients (b).
n n Obesity % Obesity OR 95% CI p-Value
(a) Disease
Whole Sample
Patients 51 26 51.0%
2.54 (1.32–4.88) 0.005 *Controls 148 43 29.1%
Male
Patients 26 16 61.5%
3.69 (1.46–9.34) 0.005 *Controls 76 23 30.3%
Female
Patients 25 10 40.0%
1.73 (0.67–4.49) 0.255Controls 72 20 27.8%
(b) Physical Activity in McArdle Patients
Whole Sample
Active 34 16 47.1%
0.69 (0.21–2.29) 0.544Inactive 16 9 56.3%
Male
Active 18 9 50.0%
0.17 (0.02–1.68) 0.102Inactive 7 6 85.7%
Female
Active 16 6 40.0%
1.00 (0.20–5.12) 1.000Inactive 9 4 40.0%
Abbreviations: CI, confidence interval; OR, odds ratio; * p < 0.05 for patients vs. controls.
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Finally, Table 6 summarizes data for the McArdle patient group in relation to the PA. There were
significant differences between male and female patients in “domestic activity” (p < 0.05).
Table 6. Physical Activity categories adjusted by age.
Activity (MET·min·week−1)
Activity Patients(n = 51)
Male Patients
(n = 26)
Female Patients
(n = 25)
Walk 1509 ± 272 1574 ± 390 1445 ± 390
Moderate 3362 ± 465 3276 ± 666 3449 ± 666
Vigorous 1401 ± 441 1413 ± 632 1389 ± 632
Work 2395 ± 656 2724 ± 940 2066 ± 940
Transport 574 ± 87 638 ± 125 511 ± 125
Domestic 1631 ± 211 1165 ± 303 2097 ± 303 *
Leisure time 1733 ± 290 1842 ± 415 1623 ± 415
Data are mean± standard deviation; Abbreviations: MET, metabolic equivalent; * p< 0.05 for male vs. female patients.
4. Discussion
This study examines the effects of McArdle disease on adiposity, especially in relation to the sex
and patient´s lifestyle (i.e., PA). Our main finding was that although McArdle patients showed similar
BMI values than controls, BF values were higher in the former compared to age- and sex-matched
controls. However, when groups were divided by sex, this difference with their counterparts was only
shown in males. In fact, this case-control study could confirm the association of McArdle disease with
obesity, increasing the risk particularly in male patients by almost four-fold. Moreover, it seems that
only female patients with an active lifestyle could reduce this adiposity in the trunk region, showing
lower BF than the inactive female patients.
According to our research, despite no differences in BMI values, both the whole-body and the
regional BF values in the McArdle group were significantly higher compared to age- and sex-matched
control subjects. Interestingly, although the patients were within the normal-weight category, the control
group was categorized as overweight or pre-obese according to the BMI classification [37]. The latter
might be due to the well-known limitations of the use of BMI for assessing actual adiposity [38].
However, when analyzing %BF, we found the opposite classification, with the McArdle patients being
considered as overweight or pre-obese [30]. Therefore, our results again reinforce the importance
of using the %BF against BMI when referring to adiposity, also in people with McArdle disease.
In addition, the risk of developing obesity was significantly increased in McArdle patients, confirming
the positive association of McArdle disease with obesity. This BF accumulation could be due to
the fact that McArdle disease has always been characterized by physical inactivity. Consequently,
a sedentary lifestyle may increase the accumulation of BF during growth, leading to a higher percentage
of BF in adult life. In relation to other glycogenosis such as Pompe disease or type II glycogenosis,
some discrepancies have been found. Adult patients with Pompe disease showed higher %BF (39.4%)
in one of the studies [39] yet lower %BF (20.7%) in another report [40]. Our results are more comparable
to those found by Papadimas et al. [39], because these authors used DXA instruments, whereas Ravaglia
et al. used anthropometry and bioelectrical impedance analysis to determine body composition [40].
Therefore, although it is difficult to compare the two conditions (i.e., McArdle vs. Pompe), both are
usually characterized by a reduced level of PA and exercise intolerance; thus, their body composition
could differ from that of disease-free individuals [39,40]. Despite both diseases showing similar mean
BMI results, below the overweight category (24.7 kg/m2 in McArdle vs. 23.7 kg/m2 in Pompe), the BF
accumulation found in McArdle disease could be a condition that develops with age. Indeed, a recent
study found no differences in the BF of children and adolescents with McArdle disease compared with
their counterparts in spite of the fact that some differences in lean and bone mass were found [41].
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Both male and female patients showed similar BMI classification and, according to their %BF,
would be classified as pre-obese [30]. Nonetheless, when comparing both male and female patients with
their corresponding control subgroups, we found that only in the case of male there were significant
differences in all regions of the body between patients and controls. Female patients showed similar
values compared to their counterparts in all body regions. Furthermore, both female controls and
patients would be categorized with the same status (i.e., pre-obese), but control males were normal
weight, which is in contrast with male McArdle patients, who were pre-obese/obese. This could be
one reason for the female subgroup’s similarity, given that male and female controls had a different
status, with females probably being less healthy than males. In addition, another reason could be the
PA, as significantly more time was spent in domestic activities by the females with McArdle disease.
In the same line, only male patients demonstrated an increased risk for obesity, showing the double
prevalence of obese subjects in the patient group (61.5% vs. 30.3%). Thus, the risk of suffering obesity is
almost four-fold higher in males with McArdle disease compared with control males. For these reasons,
it seems that male patients have a problem of adiposity, which would be especially relevant because of
the most dangerous BF accumulation (i.e., visceral). BF accumulation in males did predominate in the
abdominal area, indeed, which represents a risk factor per se for other pathologies such as diabetes,
hypertension, metabolic syndrome, or cardiovascular diseases [42,43]. Nevertheless, the PA levels
of our active male patients might not be enough to improve adiposity indices; since, as can be seen
from the Table 4, 50% of the active males had obesity against the 85.7% of the inactive patients. In fact,
in general, active patients were not significantly less likely to develop obesity, and no associations were
found between PA and BF. Whereas, it is true that in the case of female patients, there seemed to be a
significant benefit of PA, at least for the trunk area. Previous studies have shown the essential role
of PA in this clinical manifestation of the disease, with an active lifestyle alleviating, at least partly,
the consequences of a sedentary lifestyle with regard to body composition (lean and bone mass) and
quality of life [28]. The aforementioned differences between sexes could be explained by the domestic
PA, given that female patients spent significantly more time in this type of activities than male patients.
However, more knowledge is needed to understand the relationship between fat mass and physical
activity in McArdle patients.
Finally, when compared with other glycogenosis patients by sex, some discrepancies have been
found with the values previously reported in adult patients with Pompe disease. Ravaglia et al. found
a lower %BF in Pompe patients than in our McArdle patients for both sexes (male: 18.5% vs. 25.0% here;
female: 24.2% vs. 32.9%) [40], while a higher %BF was found by Papadimas et al. (male: 32.0% vs.
25.0% here; female: 46.8% vs. 32.9%) [39].
5. Limitations and Strengths
This study is not without limitations. Particularly, PA was self-reported and not objectively
assessed (e.g., using accelerometry). Nevertheless, we used a validated questionnaire with satisfactory
psychometric properties [31–33], which in fact has been previously used in this population [14,28].
Related to the control group, we did not have PA information, although eligible subjects engaged in
elite sports were excluded from the sample. Furthermore, we did not assess an important nutritional
data. In turn, this is the first study that evaluates adiposity in adult patients with McArdle disease,
thereby providing information on an important health indicator as is BF. Further, the latter was assessed
with the gold standard method, DXA. Of note is also the fact that we assessed a large sample of patients
(at least within the context of a rare condition as is McArdle disease).
6. Conclusions
Although McArdle patients showed similar BMI compared to age- and sex-matched controls,
BF was higher in the former. As for within-sex comparisons, female patients showed similar adiposity
levels than their age-matched referents, whereas male patients tended to have higher levels of adiposity
in all the body areas than male controls. Therefore, this case-control study may confirm the increased
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risk to develop obesity in McArdle patients, in particular in the case of male patients, who were had a
four-fold increased risk than controls. In addition, it seems that only female patients with an active
lifestyle could reduce adiposity in the trunk region, showing lower fat accumulation than the inactive
female patients. In this regard, special attention should be given to male patients owing to their
tendency for abdominal fat accumulation, which is marker of poor cardiometabolic health. Future
studies should further assess whether PA interventions can improve the adiposity profile of patients,
particularly in men.
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